SBIR/STTR Research Award
Diamond-based Electrodes for Retinal Prostheses
Award amount
$110,691Program and phase
STTR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NORTH COAST CRYSTALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION:
The active electrode materials currently used in retinal prostheses currently
include platinum (Pt) or iridium oxide (IrO2). Producing a sufficient signal to
evoke a visual percept, requires operating the electrode above some minimum
charge density (Qmin 0.1 - 6 mC/cm2). Both Pt and IrO2 electrodes are unable to
operate throughout this range without electrolyzing water or corroding; water
electrolysis and corrosion are detrimental to neural tissues and the device
itself.
We believe that doped-diamond electrodes, grown by chemical vapor deposition,
will operate at charge densities 6 mc/cm2 without electrolyzing water, and
resist corrosion. Therefore, we propose to 1)fabricate diamond electrodes,
2)measure in vitro the charge density at which water elecrolysis occurs, and
3)evaluate the corrosion resistance of diamond electrodes.
The small business, North Coast Crystals, and the research institution, the
University of North Carolina-Chapel Hill, will fabricate the diamond
electrodes. The retinal prosthesis group at Johns Hopkins has agreed to perform
gratis the in vitro electrode evaluation. Phase II will include demonstrating
in vivo the biocompatibility and superior performance of diamond-based
electrodes. We expect Johns Hopkins to become a Phase II partner and perform
the in vivo demonstrations.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported